Advertisement
Research Article

MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction

  • Wenliang Zhu,

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Lei Yang,

    Affiliation: The First Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Hongli Shan,

    Affiliation: Department of Pharmacology, Harbin Medical University, Harbin, China

    X
  • Yong Zhang,

    Affiliation: Department of Pharmacology, Harbin Medical University, Harbin, China

    X
  • Rui Zhou,

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Zhe Su,

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Zhimin Du mail

    dzm1956@126.com

    Affiliation: Institute of Clinical Pharmacology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China

    X
  • Published: February 28, 2011
  • DOI: 10.1371/journal.pone.0014736

Reader Comments (0)

Post a new comment on this article